Richard Marshak - 16 Nov 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

SEC form
4
Accepted by SEC
17 Nov 2026, 16:02:11 UTC
Prior SEC filing
07 Oct 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Richard Marshak filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 17 Nov 2026.

Key facts

  • This page summarizes Richard Marshak's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Nov 2026, 16:02.

Change

  • Previous filing in this sequence was filed on 07 Oct 2026.
  • Current net transaction value: -$1,322.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001982638 Primary reporting owner

Marshak Richard

Relationship
Chief Commercial Officer

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLSI transaction

Common Stock

Sale

Transaction value
-$1,322
Shares
-544
Change %
-0.43%
Price
$2.43
Shares after
127,450
Date
16 Nov 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .